| Identification | Back Directory | [Name]
Lenvervimab | [CAS]
2055006-79-4 | [Synonyms]
Lenvervimab Research Grade Lenvervimab Research Grade Lenvervimab(DVV03701) |
| Hazard Information | Back Directory | [Uses]
Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection[1][2]. | [References]
[1] Jeong GU, et al. A recombinant human immunoglobulin with coherent avidity to hepatitis B virus surface antigens of various viral genotypes and clinical mutants. PLoS One. 2020 Aug 13;15(8):e0236704. DOI:10.1371/journal.pone.0236704 [2] Lee HW, et al. Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2020 Dec;18(13):3043-3045.e1. DOI:10.1016/j.cgh.2019.09.038 |
|
| Company Name: |
Biolab Reagents
|
| Telephone: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
|